GlassScriptPhysician profile
Clyde Mcclellan Stauffer
NPI 1669909255
$4,207.25
in general payments reported to CMS, 2019-2025
15 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,862 · 2023: $123 · 2024: $95.76 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,791.65 | 2022 | |
| Elucent Medical | $81.26 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $56.60 | 2022-2025 | Keytruda, Lynparza |
| Boston Scientific Corporation | $35.42 | 2024-2025 | Overstitch Endoscopic Suturing System, Spyglass Discover |
| Innovation Technologies INC | $33.37 | 2024 | Irrisept |
| Takeda Pharmaceuticals U.S.A., INC. | $32.17 | 2023 | Gattex |
| Ambu INC. | $27.36 | 2022 | |
| Endogastric Solutions, INC | $24.45 | 2022 | |
| Integra Lifesciences Corporation | $19.81 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Conmed Corporation | $19.19 | 2023 | Airseal |
| Teleflex LLC | $18.27 | 2023 | Quikclot |
| Polynovo North America LLC | $17.97 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $17.64 | 2024 | Stravix |
| Solventum Corporation | $16.41 | 2025 | Prevena |
| Kci USA, INC. | $15.68 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clyde Stauffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.